Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год

Применить Всего найдено 36. Отображено 36.
15-10-2018 дата публикации

COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING INFLAMMATION COMPRISING SIRAITIA GROSVENORII RESIDUAL EXTRACT AS ACTIVE INGREDIENT

Номер: KR1020180113182A
Принадлежит:

The present invention relates to a composition for preventing, ameliorating, or treating inflammation, which comprises a Siraitia grosvenorii residual extract as an active ingredient. The anti-inflammatory activity of the Siraitia grosvenorii residual extract which is the active ingredient of the present invention is superior to that of a soluble part of the Siraitia grosvenorii residual extract, and the extract has excellent effects on atopic dermatitis in particular. Therefore, the composition can be used for medicine, health functional food or cosmetic industries for preventing, ameliorating or treating skin inflammation including atopic dermatitis. COPYRIGHT KIPO 2018 (AA) Siraitia grosvenorii extract ( μg /ml) (BB) Siraitia grosvenorii residue extract ( μg /ml) ...

Подробнее
27-10-2017 дата публикации

총백 추출물을 유효성분으로 함유하는 고요산혈증 또는 고요산혈증 관련 대사 장애의 예방, 개선 또는 치료용 조성물

Номер: KR0101791034B1
Принадлежит: 한국 한의학 연구원

... 본 발명은 총백 추출물을 유효성분으로 함유하는 고요산혈증 또는 고요산혈증 관련 대사 장애의 예방, 개선 또는 치료용 조성물에 관한 것으로, 본 발명의 총백 추출물은 동물모델의 혈청 내 요산을 저하시키는 효과가 있는 것으로, 천연물 유래의 유효성분이므로 안전할 뿐만 아니라, 원료 공급이 비교적 용이하므로, 고요산혈증 또는 고요산혈증 관련 대사 장애 관련 산업에 널리 활용될 수 있다. 특히, 통풍 또는 통풍성 관절염의 예방, 개선 또는 치료에 효과적으로 사용될 수 있다.

Подробнее
04-05-2018 дата публикации

COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING ARTHRITIS CONTAINING MOLLUGO PENTAPHYLLA L. EXTRACT AS ACTIVE INGREDIENT

Номер: KR1020180045537A
Принадлежит:

The present invention relates to a composition for preventing, ameliorating, or treating arthritis containing a Mollugo pentaphylla L. extract as an active ingredient. Specifically, the Mollugo pentaphylla L. extract has no cytotoxicity, shows effects of inhibiting inflammation-induced NO production and an increase of tumour necrosis factor (TNF) alpha, prostaglandin E2 (PGE2), and interleukin (IL)-6, and reduces content of IL-1β increased due to gouty arthritis. In addition, the Mollugo pentaphylla L. extract also alleviates pain caused by osteoarthritis and reduces content of inflammatory cytokines, thereby being useful for preventing, ameliorating or treating arthritis. COPYRIGHT KIPO 2018 (AA) Mollugo pentaphylla L. ethanol extract ...

Подробнее
22-05-2014 дата публикации

PHARMACEUTICAL COMPOSITION AND FUNCTIONAL HEALTH FOOD CONTAINING STRANVAESIA DAVIDIANA EXTRACT FOR PREVENTING OR TREATING DIABETES COMPLICATIONS

Номер: WO2014077426A1
Принадлежит:

The present invention relates to a pharmaceutical composition for preventing or treating diabetes complications, in which a Stranvaesia davidiana extract or a fraction thereof can be useful in preventing or treating diabetic complications, such as diabetic retinopathy or diabetic nephropathy, by effectively inhibiting vasodilation or vascular hyperplasia in animal diabetes model tests.

Подробнее
18-10-2018 дата публикации

COMPOSITION FOR PREVENTING OR IMPROVING SKIN WRINKLES CONTAINING SIRAITIA GROSVENORIIRESIDUE EXTRACT AS ACTIVE INGREDIENT

Номер: WO2018190695A1
Принадлежит:

The present invention relates to a composition for preventing or improving skin wrinkles containing a Siraitia grosvenorii residue extract as an active ingredient. The Siraitia grosvenorii residue extract as an active ingredient of the present invention has an excellent collagenase inhibitory activity as compared to a Siraitia grosvenorii extract which is a soluble fraction, and has an effect of remarkably reducing an expression amount of MMP-1 protein increased by ultraviolet irradiation, Therefore, the Siraitia grosvenorii residue extract may be effectively used for industries of cosmetics or health functional foods for preventing or improving skin wrinkles.

Подробнее
04-06-2018 дата публикации

석류풀 추출물을 유효성분으로 함유하는 관절염의 예방, 개선 또는 치료용 조성물

Номер: KR0101863603B1
Принадлежит: 한국 한의학 연구원

... 본 발명은 석류풀 추출물을 유효성분으로 함유하는 관절염의 예방, 개선 또는 치료용 조성물에 관한 것으로, 상세하게는 본 발명의 석류풀 추출물은 세포 독성이 없으며, 염증에 의해 유도되는 NO의 생성, TNFα, PGE2 및 IL-6의 증가를 억제하는 효과가 있고, 통풍성 관절염에 의해 증가된 IL-1β의 함량을 감소시킬 뿐만 아니라, 골관절염에 의한 통증을 완화시키며, 염증성 사이토카인의 함량을 감소시킴으로써, 관절염의 예방, 개선 또는 치료에 유용하게 사용할 수 있다.

Подробнее
16-02-2012 дата публикации

COMPOSITION FOR PREVENTING AND TREATING DIABETES COMPLICATIONS CONTAINING LITSEA JAPONICA EXTRACT OR FRACTION THEREOF AS ACTIVE INGREDIENT

Номер: WO2012021035A2
Принадлежит:

The present invention relates to a composition for preventing and treating diabetes complications containing Litsea japonica extract or fractions thereof as an active ingredient, and more particularly, to Litsea japonica extract or fractions thereof for suppressing the generation of an advanced glycation end product, which is an indicator of diabetes complications, and the activity of aldose reductase, preventing diabetic eye diseases (diabetic cataract and retinopathy) that are early symptoms of diabetes complications and the loss of podocytes, wherein decreasing expression of nephrin, which is a slit diagram protein that plays an important role in podocyte functions, is suppressed in particular, thereby rendering the present invention useful as the active ingredient in the composition for preventing and treating diabetes complications including diabetic nephropathy.

Подробнее
30-07-2015 дата публикации

COMPOSITION FOR PREVENTING OR TREATING PROSTATE-RELATED DISEASES, CONTAINING PONCIRUS TRIFOLIATE EXTRACT

Номер: WO2015111832A1
Принадлежит:

The present invention relates to: a pharmaceutical composition for preventing or treating prostate-related diseases, containing a Poncirus trifoliata extract or a fraction thereof as an active ingredient; a method for preventing or treating prostate-related diseases by using the composition; and a food composition, a feed composition and a quasi-drug composition for preventing or alleviating prostate-related diseases, containing a Poncirus trifoliata extract.

Подробнее
30-07-2015 дата публикации

COMPOSITION INCLUDING PONCIRI FRUCTUS EXTRACT FOR PREVENTING OR TREATING PROSTATE-RELATED DISEASE

Номер: KR1020150087794A
Принадлежит:

The present invention relates to: a pharmaceutical composition including a Ponciri fructus extract or fractions thereof as active ingredients for preventing or treating prostate-related disease; a method for preventing or treating prostate-related disease using the same composition; a food composition including a Ponciri fructus extract for preventing or alleviating prostate-related disease; a feed composition; and a quasi-drug product. COPYRIGHT KIPO 2015 (AA) Five alpha reductase activity (BB) Group 1 (CC) Group 2 (DD) Group 3 (EE) Group 4 (FF) Group 5 ...

Подробнее
04-06-2018 дата публикации

익지 추출물을 유효성분으로 함유하는 고요산혈증 또는 고요산혈증 관련 대사 장애의 예방, 개선 또는 치료용 조성물

Номер: KR0101863604B1
Принадлежит: 한국 한의학 연구원

... 본 발명은 익지 추출물을 유효성분으로 함유하는 고요산혈증 또는 고요산혈증 관련 대사 장애의 예방, 개선 또는 치료용 조성물에 관한 것으로, 본 발명의 익지 추출물은 동물모델의 혈청 내 요산을 저하시키는 효과가 있는 것으로, 천연물 유래의 유효성분이므로 안전할 뿐만 아니라, 원료 공급이 비교적 용이하므로, 고요산혈증 또는 고요산혈증 관련 대사 장애 관련 산업에 널리 활용될 수 있다. 특히, 통풍 또는 통풍성 관절염의 예방, 개선 또는 치료에 효과적으로 사용될 수 있다.

Подробнее
23-07-2018 дата публикации

관중 추출물을 유효성분으로 함유하는 고요산혈증 또는 고요산혈증 관련 대사 장애의 예방, 개선 또는 치료용 조성물

Номер: KR0101881144B1
Принадлежит: 한국 한의학 연구원

... 본 발명은 관중 추출물을 유효성분으로 함유하는 고요산혈증 또는 고요산혈증 관련 대사 장애의 예방, 개선 또는 치료용 조성물에 관한 것으로, 본 발명의 관중 추출물은 잔틴 산화효소의 활성을 저해할 뿐만 아니라, 동물모델의 혈청 내 요산량을 감소시키는 효과가 있는 것으로, 천연물 유래의 유효성분이므로 안전할 뿐만 아니라, 원료 공급이 비교적 용이하므로, 고요산혈증 또는 고요산혈증 관련 대사 장애 관련 산업에 널리 활용될 수 있다. 특히, 통풍 또는 통풍성 관절염의 예방, 개선 또는 치료에 효과적으로 사용될 수 있다.

Подробнее
01-03-2012 дата публикации

PHARMACEUTICAL COMPOSITION CONTAINING MELASTOMA SANGUINEUM EXTRACTS OR FRACTIONS THEREOF AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING DIABETIC COMPLICATIONS

Номер: WO2012026748A2
Принадлежит:

The present invention relates to a composition containing Melastoma sanguineum extracts or fractions thereof as active ingredients for preventing or treating diabetic complications. More particularly, Melastoma sanguineum extracts, or ethyl acetate fractions and n-butanol fractions which are systematic fractions thereof, inhibit the formation of advanced glycation end-products as well as the activity of aldose reductases, which may serve as an index of the onset of diabetic complications. The Melastoma sanguineum extracts or ethyl acetate fractions and n-butanol fractions have the effects of potently inhibiting vasodilatation caused by hyperglycemia in zebrafish, which are vertebrates, and inhibiting diabetic complications when administered to animal models for diabetic disease. Therefore, the Melastoma sanguineum extracts or ethyl acetate fractions and n-butanol fractions, which are systematic fractions thereof, according to the present invention may be used as active ingredients for a ...

Подробнее
23-02-2012 дата публикации

COMPOSITION FOR PREVENTING AND TREATING COMPLICATIONS OF DIABETES MELLITUS, CONTAINING BRANDISIA HANCEI HOOK. F. EXTRACT OR FRACTION THEREOF AS ACTIVE INGREDIENT

Номер: WO2012023803A3
Принадлежит:

The present invention relates to a composition for preventing and treating complications of diabetes mellitus, containing a Brandisia hancei Hook. f. extract or a fraction thereof as an active ingredient. More specifically, a Brandisia hancei Hook. f. extract or a fraction thereof inhibits the generation of an advanced glycation end product, which is an indicator of diabetes mellitus complications, and the activity of aldose reductase, and is strongly effective for complications of diabetes mellitus including diabetic retinopathy,and thus can be useful as an active ingredient of a composition for preventing and treating complications of diabetes mellitus.

Подробнее
23-02-2012 дата публикации

COMPOSITION FOR PREVENTING AND TREATING COMPLICATIONS OF DIABETES MELLITUS, CONTAINING BRANDISIA HANCEI HOOK. F. EXTRACT OR FRACTION THEREOF AS ACTIVE INGREDIENT

Номер: WO2012023803A2
Принадлежит:

The present invention relates to a composition for preventing and treating complications of diabetes mellitus, containing a Brandisia hancei Hook. f. extract or a fraction thereof as an active ingredient. More specifically, a Brandisia hancei Hook. f. extract or a fraction thereof inhibits the generation of an advanced glycation end product, which is an indicator of diabetes mellitus complications, and the activity of aldose reductase, and is strongly effective for complications of diabetes mellitus including diabetic retinopathy,and thus can be useful as an active ingredient of a composition for preventing and treating complications of diabetes mellitus.

Подробнее
16-02-2012 дата публикации

COMPOSITION FOR PREVENTING AND TREATING DIABETES COMPLICATIONS INCLUDING SPENCERIA RAMALANA EXTRACT OR FRACTION THEREOF AS ACTIVE INGREDIENT

Номер: WO2012021038A2
Принадлежит:

The present invention relates to a composition for preventing and treating diabetes complications including Speceria ramalana extract or fractions thereof as an active ingredient, and more particularly, to Spenceria ramalana extract or fractions thereof, which suppresses the generation of an advanced glycation end product, which is an indicator of diabetes complications, suppresses the activity of aldose reductase, and shows effective and significant prevention and treatment of diabetic retinopathy, thereby rendering the present invention useful as the active ingredient in the composition for preventing and treating various diabetes complications including diabetic retinopathy.

Подробнее
12-10-2017 дата публикации

COMPOSITION CONTAINING ALPINIA FRUCTUS EXTRACT AS ACTIVE INGREDIENT FOR PREVENTING, ALLEVIATING, OR TREATING HYPERURICEMIA OR HYPERURICEMIA-RELATED METABOLIC DISORDER

Номер: WO2017176082A1
Принадлежит:

The present invention relates to a composition containing an Alpinia fructus extract as an active ingredient for preventing, alleviating, or treating hyperuricemia or a hyperuricemia-related metabolic disorder. The Alpinia fructus extract of the present invention, which has an effect of reducing uric acid in serum in an animal model, is safe since the extract is a natural material-derived active ingredient, and can be widely utilized in industries associated with hyperuricemia or a hyperuricemia-related metabolic disorder since a raw material of the extract is comparatively easily supplied. Especially, the Alpinia fructus extract of the present invention can be effectively used in the prevention, alleviation, or treatment of gout or gouty arthritis.

Подробнее
07-10-2016 дата публикации

지실 추출물을 포함하는 전립선 관련 질환의 예방 또는 치료용 조성물

Номер: KR0101662719B1
Принадлежит: 한국 한의학 연구원

... 본 발명은 지실 추출물 또는 이의 분획물을 유효성분으로 포함하는 전립선 관련 질환의 예방 또는 치료용 약학 조성물, 상기 조성물을 이용한 전립선 관련 질환의 예방 또는 치료 방법, 지실 추출물을 포함하는 전립선 관련 질환의 예방 또는 개선용 식품 조성물, 사료용 조성물, 및 의약외품 조성물에 관한 것이다.

Подробнее
16-10-2018 дата публикации

METHOD FOR MANUFACTURING GINSENG EXTRACT RESIDUE FOR PREVENTING OR ALLEVIATING SKIN WRINKLES USING ACID SOLUTION

Номер: KR101907918B1
Принадлежит: KOREA INSTITUTE OF ORIENTAL MEDICINE

The present invention relates to a method for manufacturing ginseng extract residue by adding an acid solution to a ginseng extract, and to a cosmetic composition for preventing or alleviating skin wrinkles containing the ginseng extract residue as an active ingredient. Since the active ingredient of the present invention has excellent collagenase inhibitory activity, the composition can be useful for the cosmetic industry for preventing or alleviating the skin wrinkles. COPYRIGHT KIPO 2018 (AA) Ginseng extract (0% of acetic acid) (BB) Acetic acid addition concentration (400 μg /ml of ginseng extract residue) ...

Подробнее
22-05-2014 дата публикации

PHARMACEUTICAL COMPOSITION AND FUNCTIONAL HEALTH FOOD CONTAINING CARPINUS CORDATA EXTRACT FOR PREVENTING OR TREATING DIABETES COMPLICATIONS

Номер: WO2014077424A1
Принадлежит:

The present invention relates to an agent treating for diabetes complications and a method for treating diabetes complications by using same, in which a Capinus cordata extract or a fraction thereof inhibits the generation of advanced glycation end-products, which are indicators of an outbreak of diabetes complications, and which can be useful as an agent for preventing or treating diabetic complications by having superior effects on preventing or treating diabetic ophthalmic diseases in animal diabetic model tests.

Подробнее
18-10-2017 дата публикации

COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING HYPERURICEMIA OR METABOLIC DISORDERS ASSOCIATED WITH HYPERURICEMIA COMPRISING EXTRACT OF ALLII RADIX AS EFFECTIVE COMPONENT

Номер: KR1020170115836A
Принадлежит:

The present invention relates to a composition for preventing, alleviating or treating hyperuricemia or metabolic disorders associated with hyperuricemia comprising an extract of Allii radix as an effective component. The extract of Allii radix of the present invention is effective in reducing uric acid in a serum of an animal model, is safe as an effective component derived from natural materials and can supply raw materials in a relatively easy manner, thereby being widely used in industries for hyperuricemia or metabolic disorders associated with hyperuricemia. Especially, the extract can be effectively used for preventing, alleviating or treating gout or gouty arthritis. COPYRIGHT KIPO 2017 (AA) Allii radix (mg/kg) ...

Подробнее
03-05-2018 дата публикации

COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING ARTHRITIS, CONTAINING EXTRACT OF MOLLUGO PENTAPHYLLA AS ACTIVE INGREDIENT

Номер: WO2018080054A1
Принадлежит:

The present invention relates to a composition for preventing, alleviating or treating arthritis, containing an extract of Mollugo pentaphylla as an active ingredient. More specifically, the Mollugo pentaphylla extract of the present invention is not cytotoxic, has an effect of inhibiting the generation of NO, induced by inflammation, and the increase in TNFα, PGE2, and IL-6, reduces the IL-1β amount increased because of gouty arthritis, relieves pain caused by osteoarthritis, and reduces the amount of inflammatory cytokines, thereby being usable in the prevention, alleviation or treatment of arthritis.

Подробнее
16-02-2012 дата публикации

COMPOSITION FOR PREVENTING AND TREATING DIABETES COMPLICATIONS CONTAINING LITSEA JAPONICA EXTRACT OR FRACTION THEREOF AS ACTIVE INGREDIENT

Номер: WO2012021035A3
Принадлежит:

The present invention relates to a composition for preventing and treating diabetes complications containing Litsea japonica extract or fractions thereof as an active ingredient, and more particularly, to Litsea japonica extract or fractions thereof for suppressing the generation of an advanced glycation end product, which is an indicator of diabetes complications, and the activity of aldose reductase, preventing diabetic eye diseases (diabetic cataract and retinopathy) that are early symptoms of diabetes complications and the loss of podocytes, wherein decreasing expression of nephrin, which is a slit diagram protein that plays an important role in podocyte functions, is suppressed in particular, thereby rendering the present invention useful as the active ingredient in the composition for preventing and treating diabetes complications including diabetic nephropathy.

Подробнее
01-03-2012 дата публикации

PHARMACEUTICAL COMPOSITION CONTAINING MELASTOMA SANGUINEUM EXTRACTS OR FRACTIONS THEREOF AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING DIABETIC COMPLICATIONS

Номер: WO2012026748A3
Принадлежит:

The present invention relates to a composition containing Melastoma sanguineum extracts or fractions thereof as active ingredients for preventing or treating diabetic complications. More particularly, Melastoma sanguineum extracts, or ethyl acetate fractions and n-butanol fractions which are systematic fractions thereof, inhibit the formation of advanced glycation end-products as well as the activity of aldose reductases, which may serve as an index of the onset of diabetic complications. The Melastoma sanguineum extracts or ethyl acetate fractions and n-butanol fractions have the effects of potently inhibiting vasodilatation caused by hyperglycemia in zebrafish, which are vertebrates, and inhibiting diabetic complications when administered to animal models for diabetic disease. Therefore, the Melastoma sanguineum extracts or ethyl acetate fractions and n-butanol fractions, which are systematic fractions thereof, according to the present invention may be used as active ingredients for a ...

Подробнее
13-09-2012 дата публикации

PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING COMPLICATIONS OF DIABETES CONTAINING A TRADITIONAL ORIENTAL MEDICINE EXTRACT OR A FRACTION THEREOF AS AN ACTIVE INGREDIENT

Номер: WO2012121423A8
Принадлежит:

The present invention relates to a pharmaceutical composition for preventing and treating complications of diabetes containing Homonoia riparia Lour. extract or a fraction thereof as an active ingredient, and, more specifically, the Homonoia riparia Lour. extract or the fraction thereof suppresses the action of aldose reductase and the production of advanced glycosylated end products which are indicators of complications of diabetes, and exhibits a powerful action in suppressing complications of diabetes via its effects in countering cataracts, retinopathy and nephropathy, and thus can be used to advantage as an active ingredient in a pharmaceutical composition for preventing and treating complications of diabetes.

Подробнее
13-09-2012 дата публикации

PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING COMPLICATIONS OF DIABETES CONTAINING A TRADITIONAL ORIENTAL MEDICINE EXTRACT OR A FRACTION THEREOF AS AN ACTIVE INGREDIENT

Номер: WO2012121423A1
Принадлежит:

The present invention relates to a pharmaceutical composition for preventing and treating complications of diabetes containing Homonoia riparia Lour. extract or a fraction thereof as an active ingredient, and, more specifically, the Homonoia riparia Lour. extract or the fraction thereof suppresses the action of aldose reductase and the production of advanced glycosylated end products which are indicators of complications of diabetes, and exhibits a powerful action in suppressing complications of diabetes via its effects in countering cataracts, retinopathy and nephropathy, and thus can be used to advantage as an active ingredient in a pharmaceutical composition for preventing and treating complications of diabetes.

Подробнее
16-10-2018 дата публикации

COMPOSITION FOR PREVENTING OR REDUCING SKIN WRINKLES COMPRISING SIRAITIA GROSVENORII RESIDUAL EXTRACT AS EFFECTIVE COMPONENT

Номер: KR101907919B1
Принадлежит: KOREA INSTITUTE OF ORIENTAL MEDICINE

The present invention relates to a composition for preventing or reducing skin wrinkles comprising a Siraitia grosvenorii residual extract as an effective component. The collagenase inhibitory activity of the Siraitia grosvenorii residual extract, which is an effective component of the present invention, is superior to a Siraitia grosvenorii extract, which is a soluble fraction. Thus the composition of the present invention can be usefully used in the cosmetic industry to prevent or reduce skin wrinkles. COPYRIGHT KIPO 2018 (AA) Siraitia grosvenorii residual extract concentration (μg /ml) (BB) Siraitia grosvenorii extract (CC) Siraitia grosvenorii residual extract ...

Подробнее
12-05-2011 дата публикации

COMPOSITIONS FOR TREATMENT AND PREVENTION OF DIABETIC COMPLICATIONS USING OSTEOMELES SCHWERINAE

Номер: KR2011055869A1
Принадлежит:

The present invention relates to a therapeutic agent for diabetic complications and a treatment method for diabetic complications using the same, and more specifically, to an agent for prevention and treatment of diabetic complications containing extracts and fractions of Osteomeles schwerinae as active ingredients, wherein the extracts and fractions of Osteomeles schwerinae are confirmed to prevent the generation of advanced glycation endproducts, which is an indicator of diabetic complications, and the activation of aldose reductase, and to have an anti-cataract effect and anti-oxidative activity.

Подробнее
16-02-2012 дата публикации

COMPOSITION FOR PREVENTING AND TREATING DIABETES COMPLICATIONS INCLUDING SPENCERIA RAMALANA EXTRACT OR FRACTION THEREOF AS ACTIVE INGREDIENT

Номер: WO2012021038A3
Принадлежит:

The present invention relates to a composition for preventing and treating diabetes complications including Speceria ramalana extract or fractions thereof as an active ingredient, and more particularly, to Spenceria ramalana extract or fractions thereof, which suppresses the generation of an advanced glycation end product, which is an indicator of diabetes complications, suppresses the activity of aldose reductase, and shows effective and significant prevention and treatment of diabetic retinopathy, thereby rendering the present invention useful as the active ingredient in the composition for preventing and treating various diabetes complications including diabetic retinopathy.

Подробнее
12-04-2018 дата публикации

COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING HYPERLIPIDEMIA OR HYPERLIPIDEMIA-RELATED METABOLIC DISORDERS CONTAINING BUCKLER FERN EXTRACT AS ACTIVE INGREDIENT

Номер: KR1020180037496A
Принадлежит:

The present invention relates to a composition for preventing, ameliorating or treating hyperlipidemia or hyperlipidemia-related metabolic disorders containing a buckler fern extract as an active ingredient. The buckler fern extract of the present invention not only inhibits activities of xanthine oxidase but also has effects of reducing uric acid amounts in serum of an animal model. Since the composition is an active ingredient derived from natural materials, the composition is safe and can be widely used in industries related to hyperlipidemia or hyperlipidemia-related metabolic disorders owing to relatively easiness in supplying raw materials. In particular, the composition can be effectively used for preventing, improving or treating gout or gouty arthritis. COPYRIGHT KIPO 2018 (AA,CC) Normal bacteria (BB,DD) Hyperuricemia (EE) Dryopteris crassirhizoma ...

Подробнее
16-02-2012 дата публикации

NOVEL BIPHENYL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR PREPARING NOVEL BIPHENYL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING DIABETES COMPLICATIONS

Номер: WO2012021013A3
Принадлежит:

The present invention aims to provide a novel biphenyl compound or a pharmaceutically acceptable salt thereof, a method for preparing the novel biphenyl compound or pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing same as an active ingredient for preventing or treating diabetes complications. The novel biphenyl compound, according to the present invention, effectively suppresses generation activity of an advanced glycation end product, which causes diabetes complications and is a criterion for evaluating the effectiveness of a treating agent for diabetes complications, and shows effective treatment of retinal veins on the retina subject to diabetic retinopathy, increased occluding, and decreased angiogenesis growth factors, thereby rendering the novel biphenyl compound invention useful as an active ingredient in a composition for preventing or treating diabetes complications such as diabetic retinopathy.

Подробнее
16-02-2012 дата публикации

NOVEL BIPHENYL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR PREPARING NOVEL BIPHENYL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING DIABETES COMPLICATIONS

Номер: WO2012021013A2
Принадлежит:

The present invention aims to provide a novel biphenyl compound or a pharmaceutically acceptable salt thereof, a method for preparing the novel biphenyl compound or pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing same as an active ingredient for preventing or treating diabetes complications. The novel biphenyl compound, according to the present invention, effectively suppresses generation activity of an advanced glycation end product, which causes diabetes complications and is a criterion for evaluating the effectiveness of a treating agent for diabetes complications, and shows effective treatment of retinal veins on the retina subject to diabetic retinopathy, increased occluding, and decreased angiogenesis growth factors, thereby rendering the novel biphenyl compound invention useful as an active ingredient in a composition for preventing or treating diabetes complications such as diabetic retinopathy.

Подробнее
22-05-2014 дата публикации

PHARMACEUTICAL COMPOSITION AND FUNCTIONAL HEALTH FOOD CONTAINING PAULOWNIA EXTRACT FOR PREVENTING OR TREATING DIABETES COMPLICATIONS

Номер: WO2014077425A1
Принадлежит:

The present invention relates to an agent for treating diabetes complications and a method for treating diabetes complications by using same, in which a Paulownia extract or a fraction thereof inhibits the generation of advanced glycation end-products, which are indicators of an outbreak of diabetes complications, and which can be useful as an agent for preventing or treating diabetic complications by having superior effects on preventing or treating diabetic ophthalmic diseases in animal diabetic model tests.

Подробнее
11-10-2018 дата публикации

COMPOSITION, CONTAINING SIRAITIA GROSVENORII RESIDUE EXTRACT AS ACTIVE INGREDIENT, FOR PREVENTION, ALLEVIATION, OR TREATMENT OF INFLAMMATION

Номер: WO2018186705A1
Принадлежит:

The present invention relates to a composition, containing a Siraitia grosvenorii residue extract as an active ingredient, for prevention, alleviation, or treatment of inflammation. The Siraitia grosvenorii residue extract as an active ingredient of the present invention has superior anti-inflammatory activity to a Siraitia grosvenorii extract as a soluble part, and especially, has an excellent effect on atopic dermatitis, and thus the present invention can be advantageously used in the industries of medicines, health functional foods, or cosmetic materials for prevention, alleviation, or treatment of dermatitis including atopic dermatitis.

Подробнее
10-05-2018 дата публикации

PACKING PAPER FOR DELIVERY AND PACKING PAPER BAG MADE THEREBY

Номер: KR1020180047279A
Автор: KIM, ON SUN
Принадлежит:

The present invention relates to a packing paper for a delivery and a packing paper bag made thereby. In a prior art, a paper box for a delivery is used for singular packing. In the present invention, the packing paper bag can be used for safely packing for a delivery such that packing costs in general (paper box space cost, time saving for granule packing, costs saving compared to that of paper boxes, and the like) can be reduced, the packing paper bag can be easily and conveniently used, and production costs can be reduced. In addition, users are able to use the packing paper for a delivery more conveniently and sellers are able to pack products in a better quality by using the packing paper bag. COPYRIGHT KIPO 2018 ...

Подробнее
12-04-2018 дата публикации

COMPOSITION COMPRISING CRASSIRHIZOMAE RHIZOMA EXTRACT AS ACTIVE INGREDIENT FOR PREVENTING, ALLEVIATING, OR TREATING HYPERURICEMIA OR HYPERURICEMIA-RELATED METABOLIC DISORDERS

Номер: WO2018066952A1
Принадлежит:

The present invention relates to a composition comprising a Crassirhizomae Rhizoma extract as an active ingredient for preventing, alleviating, or treating hyperuricemia or hyperuricemia-related metabolism disorders. The Crassirhizomae Rhizoma extract of the present invention has effects of reducing the serum uric acid content in animal models as well as inhibiting activity of xanthine oxidase. The Crassirhizomae Rhizoma extract is safe and a raw material therefor is relatively easy to supply since the extract is an active ingredient derived from a natural material, so that the extract can be widely utilized in industries associated with hyperuricemia or hyperuricemia-related metabolic disorders. Particularly, the extract can be effectively used in the prevention, alleviation, or treatment of gout or gouty arthritis.

Подробнее
18-10-2017 дата публикации

COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING HYPERURICEMIA OR METABOLIC DISORDERS ASSOCIATED WITH HYPERURICEMIA COMPRISING EXTRACT OF ALPINIAE FRUCTUS AS EFFECTIVE COMPONENT

Номер: KR1020170115838A
Принадлежит:

The present invention relates to a composition for preventing, alleviating or treating hyperuricemia or metabolic disorders associated with hyperuricemia comprising an extract of Alpiniae fructus as an effective component. The extract of Alpiniae fructus of the present invention is effective in reducing uric acid in a serum of an animal model, is safe as an effective component derived from natural materials and can supply raw materials in a relatively easy manner, thereby being widely used in industries for hyperuricemia or metabolic disorders associated with hyperuricemia. Especially, the extract can be effectively used for preventing, alleviating or treating gout or gouty arthritis. COPYRIGHT KIPO 2017 (AA) Alpiniae fructus (mg/kg) ...

Подробнее